Genetic Variant of PP2A Subunit Gene Confers an Increased Risk of Primary Liver Cancer in Chinese

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• He Y, Lu M, Che J, Chu Q, Zhang P, Chen Y. Biomarkers and future perspectives for hepatocellular carcinoma immunotherapy. Front Oncol. 2021;11:716844. doi:10.3389/fonc.2021.716844
   PubMed Web of Science ®Google Scholar
• Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China. Cancer Lett. 2018;412:283–288. doi:10.1016/j.canlet.2017.10.008
   PubMed Web of Science ®Google Scholar
• Zhang CY, Huang TR, Yu JH, et al. Epidemiological analysis of primary liver cancer in the early 21st century in Guangxi province of China. Chin J Cancer. 2010;29(5):545–550. doi:10.5732/cjc.009.10510
   Google Scholar
• Ueno Y, Nagata S, Tsutsumi T, et al. Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis. 1996;17(6):1317–1321. doi:10.1093/carcin/17.6.1317
   PubMed Web of Science ®Google Scholar
• Xiang X, Qin HG, You XM, et al. Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure. Cancer Med. 2017;6(10):2357–2369. doi:10.1002/cam4.1176
   PubMed Web of Science ®Google Scholar
• Mai H, Xie H, Hou J, et al. A genetic variant of PPP1CB influences risk of hepatitis B virus-related hepatocellular carcinoma in Han Chinese: a pathway based analysis. J Hepatocell Carcinoma. 2021;8:1055–1064. doi:10.2147/JHC.S321939
   Web of Science ®Google Scholar
• Long XD, Zhao D, Wang C, et al. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma. Epidemiology. 2013;24(5):671–681. doi:10.1097/EDE.0b013e31829d2744
   Web of Science ®Google Scholar
• Xiao C, Mei F, Ren G, et al. Synergistic effect of MC-LR and C-terminal truncated HBx on HepG2 cells and their effects on PP2A mediated downstream target of MAPK signaling pathway. Front Genet. 2020;11:537785. doi:10.3389/fgene.2020.537785
   Web of Science ®Google Scholar
• Jia X, Guan B, Liao J, et al. Down-regulation of GCLC is involved in microcystin-LR-induced malignant transformation of human liver cells. Toxicology. 2019;421:49–58. doi:10.1016/j.tox.2019.03.010
   PubMed Web of Science ®Google Scholar
• Lei X, Ma N, Du L, et al. PP2A and tumor radiotherapy. Hereditas. 2020;157(1):36. doi:10.1186/s41065-020-00149-7
   Web of Science ®Google Scholar
• Sandal P, Jong CJ, Merrill RA, Song J, Strack S. Protein phosphatase 2A – structure, function and role in neurodevelopmental disorders. J Cell Sci. 2021;134(13):jcs248187. doi:10.1242/jcs.248187
   Web of Science ®Google Scholar
• Taylor SE, O’Connor CM, Wang Z, et al. The highly recurrent PP2A Aα-subunit mutation P179R alters protein structure and impairs PP2A enzyme function to promote endometrial tumorigenesis. Cancer Res. 2019;79(16):4242–4257. doi:10.1158/0008-5472.CAN-19-0218
   Web of Science ®Google Scholar
• Sablina AA, Hector M, Colpaert N, Hahn WC. Identification of PP2A complexes and pathways involved in cell transformation. Cancer Res. 2010;70(24):10474–10484. doi:10.1158/0008-5472.CAN-10-2855
   Web of Science ®Google Scholar
• Fowle H, Zhao Z, Graña X. PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer. Adv Cancer Res. 2019;144:55–93.
   Web of Science ®Google Scholar
• Lin YC, Chen HF, Lin LN, et al. Identification and functional analyses of polymorphism haplotypes of protein phosphatase 2A-Aα gene promoter. Mutat Res. 2011;716(1–2):66–75. doi:10.1016/j.mrfmmm.2011.08.004
   Web of Science ®Google Scholar
• Huang T, He K, Mao Y, et al. Genetic variants in PPP2CA are associated with gastric cancer risk in a Chinese population. Sci Rep. 2017;7(1):11499. doi:10.1038/s41598-017-12040-z
   Web of Science ®Google Scholar
• Cheng Y, Liu W, Kim ST, et al. Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study. Cancer Genet. 2011;204(7):375–381. doi:10.1016/j.cancergen.2011.05.002
   Web of Science ®Google Scholar
• Chen HF, Mai JR, Wan JX, et al. Role of a novel functional variant in the PPP2R1A promoter on the regulation of PP2A-Aα and the risk of hepatocellular carcinoma. PLoS One. 2013;8(3):e59574. doi:10.1371/journal.pone.0059574
   Web of Science ®Google Scholar
• Yang R, Yang L, Qiu F, et al. Functional genetic polymorphisms in PP2A subunit genes confer increased risks of lung cancer in southern and eastern Chinese. PLoS One. 2013;8(10):e77285. doi:10.1371/journal.pone.0077285
   Web of Science ®Google Scholar
• Dupont WD, Breyer JP, Bradley KM, et al. Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk. Cancer. 2010;116(1):8–19. doi:10.1002/cncr.24702
   Web of Science ®Google Scholar
• Grochola LF, Vazquez A, Bond EE, et al. Recent natural selection identifies a genetic variant in a regulatory subunit of protein phosphatase 2A that associates with altered cancer risk and survival. Clin Cancer Res. 2009;15(19):6301–6308. doi:10.1158/1078-0432.CCR-09-0797
   Web of Science ®Google Scholar
• Jeong AL, Han S, Lee S, et al. Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway. Sci Rep. 2016;6(1):27391. doi:10.1038/srep27391
   Web of Science ®Google Scholar
• Nobumori Y, Shouse GP, Wu Y, Lee KJ, Shen B, Liu X. B56 tumor-associated mutations provide new mechanisms for B56 -PP2A tumor suppressor activity. Mol Cancer Res. 2013;11(9):995–1003. doi:10.1158/1541-7786.MCR-12-0633
   Web of Science ®Google Scholar
• Stockwell HG, Goldman AL, Lyman GH, et al. Environmental tobacco smoke and lung cancer risk in nonsmoking women. J Natl Cancer Inst. 1992;84(18):1417–1422. doi:10.1093/jnci/84.18.1417
   Google Scholar
• Ruidavets JB, Evans A, Montaye M, et al. Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: the prospective epidemiological study of myocardial infarction (PRIME). BMJ. 2010;341:c6077. doi:10.1136/bmj.c6077
   Web of Science ®Google Scholar
• Li X, Zhao Q, Zhou W, Xu L, Wang Y. Effects of chronic exposure to microcystin-LR on hepatocyte mitochondrial DNA replication in mice. Environ Sci Technol. 2015;49(7):4665–4672. doi:10.1021/es5059132
   Web of Science ®Google Scholar
• Yang L, Li Y, Cheng M, et al. A functional polymorphism at microRNA-629-binding site in the 3ʹ-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis. 2012;33(2):338–347. doi:10.1093/carcin/bgr272
   PubMed Web of Science ®Google Scholar
• Xu C, He D, Zu Y, Hong S, Hao J, Li J. Microcystin-LR heterologous genetically engineered antibody recombinant and its binding activity improvement and application in immunoassay. J Hazard Mater. 2021;406:124596. doi:10.1016/j.jhazmat.2020.124596
   Web of Science ®Google Scholar
• Kuhn E, Wu RC, Guan B, et al. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. J Natl Cancer Inst. 2012;104(19):1503–1513. doi:10.1093/jnci/djs345
   Google Scholar
• Yang H, Huo J, Li X. Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma. World J Surg Oncol. 2021;19(1):90. doi:10.1186/s12957-021-02202-9
   PubMed Web of Science ®Google Scholar
• Chen J, Zhu J, Wang G, Groopman JD, Kensler TW. Qidong: a crucible for studies on liver cancer etiology and prevention. Cancer Biol Med. 2019;16(1):24–37. doi:10.20892/j.issn.2095-3941.2018.0394
   Web of Science ®Google Scholar
• Yu SZ. Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol. 1995;10(6):674–682. doi:10.1111/j.1440-1746.1995.tb01370.x
   PubMed Web of Science ®Google Scholar
• Duy TN, Lam PK, Shaw GR, Connell DW. Toxicology and risk assessment of freshwater cyanobacterial (blue-green algal) toxins in water. Rev Environ Contam Toxicol. 2000;163:113–185. doi:10.1007/978-1-4757-6429-1_3
   PubMed Web of Science ®Google Scholar
• Kordasht HK, Hassanpour S, Baradaran B, et al. Biosensing of microcystins in water samples; recent advances. Biosens Bioelectron. 2020;165:112403. doi:10.1016/j.bios.2020.112403
   PubMed Web of Science ®Google Scholar
• IARC monographs on the evaluation of carcinogenic risks to humans. Ingested nitrate and nitrite, and cyanobacterial peptide toxins. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; 2010.
   Google Scholar
• Fontanillo M, Kohn M. Microcystins: synthesis and structure-activity relationship studies toward PP1 and PP2A. Bioorg Med Chem. 2018;26(6):1118–1126. doi:10.1016/j.bmc.2017.08.040
   Web of Science ®Google Scholar